Volume 19 Issue 6
Jun.  2021
Turn off MathJax
Article Contents
ZOU Chun-yu, YUE Chen, YANG Lan-bo, MI Yu-fei, WANG Zhan-chao. Safety and effectiveness of tranexamic acid in patients combined with high risk comorbidities for postoperative venous thromboembolism during total knee arthroplasty[J]. Chinese Journal of General Practice, 2021, 19(6): 901-903. doi: 10.16766/j.cnki.issn.1674-4152.001945
Citation: ZOU Chun-yu, YUE Chen, YANG Lan-bo, MI Yu-fei, WANG Zhan-chao. Safety and effectiveness of tranexamic acid in patients combined with high risk comorbidities for postoperative venous thromboembolism during total knee arthroplasty[J]. Chinese Journal of General Practice, 2021, 19(6): 901-903. doi: 10.16766/j.cnki.issn.1674-4152.001945

Safety and effectiveness of tranexamic acid in patients combined with high risk comorbidities for postoperative venous thromboembolism during total knee arthroplasty

doi: 10.16766/j.cnki.issn.1674-4152.001945
Funds:

 81804126

  • Received Date: 2020-07-06
    Available Online: 2022-02-16
  •   Objective  To assess the safety and efficacy of tranexamic acid (TXA) in patients with high risk comorbidities for venous thromboembolic events (VTE) during total knee arthroplasty (TKA).  Methods  We chose eight risk factors for postoperative VTE during TKA. Patients in Luoyang Orthopedic Hospital of Henan Province were reviewed from January 2010 to December 2019 and were divided into control, intravenous TXA, and topical TXA group. The safety outcomes were identified as the incidence of VTE, and the efficacy outcome was limited to transfusions.  Results  Through a comprehensive review of 7 836 consecutive TKA cases from 2010 to 2019, 781 cases were included according to the inclusion criteria. Of them, 341 cases didn't receive TXA, 163 patients received intravenous TXA and 277 patients received topical TXA. The incidence of VTE was not significant difference across these three groups (8.50% vs. 9.82% vs. 7.94%), and the transfusion rate was significantly lower in the intravenous and topical TXA groups than the control group (31.67% vs. 18.40% vs. 22.38%, P=0.002).  Conclusion  This study preliminary showed that TXA was effective to decrease transfusions without sacrificing the safety in patients with high risk comorbidities for VTE during TKA.

     

  • loading
  • [1]
    岳辰, 周宗科, 裴福兴, 等. 中国髋、膝关节置换术围术期抗纤溶药序贯抗凝血药应用方案的专家共识[J]. 中华骨与关节外科杂志, 2015, 8(4): 281-285. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGJW201504001.htm
    [2]
    YAMAGUCHI A, GOTO K, KAWAI T, et al. Dose optimization of topical tranexamic acid for primary total hip arthroplasty: a prospective cohort study[J]. J Orthop Sci, 2018, 24(2): 275-279. http://www.onacademic.com/detail/journal_1000040872053910_fc52.html
    [3]
    GULABI D, YUCE Y, EEKAL K H, et al. The combined administration of systemic and topical tranexamic acid for total hip arthroplasty: Is it better than systemic?[J]. Acta Orthop Traumatol Turc, 2019, 53(4): 297-300. doi: 10.1016/j.aott.2019.03.001
    [4]
    DURGUT F, ERKOCAK O F, AYDIN B K, et al. A comparison of the effects on postoperative bleeding of the intra-articular application of tranexamic acid and adrenalin in total knee arthroplasty[J]. J Pak Med Assoc, 2019, 69(3): 325-329. http://www.ncbi.nlm.nih.gov/pubmed/30890822
    [5]
    DAI W L, ZHOU A G, ZHANG H, et al. Most effective regimen of tranexamic acid for reducing bleeding and transfusions in primary total knee arthroplasty: a meta-analysis of randomized controlled trials[J]. J Knee Surg, 2018, 31(7): 654-663. doi: 10.1055/s-0037-1606376
    [6]
    CHAMBERS S, TIDWELL L, KERKHOF A, et al. Topical tranexamic acid is effective in cementless total knee arthroplasty[J]. Orthop Clin North Am, 2020, 51(1): 7-11. doi: 10.1016/j.ocl.2019.08.002
    [7]
    AYTULUK H G, YAKA H O. Tranexamic acid is effective in lower doses with infusion in total knee arthroplasty[J]. Acta Orthop Traumatol Turc, 2019, 53(2): 81-85. doi: 10.1016/j.aott.2018.12.002
    [8]
    YAZDI H, KLEMENT M R, HAMMAD M, et al. Tranexamic acid is associated with reduced periprosthetic joint infection after primary total joint arthroplasty[J]. J Arthroplasty, 2020, 35(3): 840-844. doi: 10.1016/j.arth.2019.10.029
    [9]
    WHITING D R, GILLETTE B P, DUNCAN C, et al. Preliminary results suggest tranexamic acid is safe and effective in arthroplasty patients with severe comorbidities[J]. Clin Orthop Relat Res, 2014, 472(1): 66-72. doi: 10.1007/s11999-013-3134-0
    [10]
    SHIN W C, WOO S H, LEE S J, et al. Preoperative prevalence of and risk factors for venous thromboembolism in patients with a hip fracture: an indirect multidetector CT venography study[J]. J Bone Joint Surg Am, 2016, 98(24): 2089-2095. doi: 10.2106/JBJS.15.01329
    [11]
    DAI W L, LIN Z M, SHI Z J, et al. Venous thromboembolic events after total knee arthroplasty: Which patients are at a high risk?[J]. J Knee Surg, 2020, 33(10): 947-957. doi: 10.1055/s-0039-1688962
    [12]
    LU Y, ZHOU Z Y, LIU Y K, et al. Gender differences of venous thromboembolism risk after total hip and total knee arthroplasty: a meta-analysis[J]. J Thromb Thrombolysis, 2016, 41(4): 556-562. doi: 10.1007/s11239-015-1283-6
    [13]
    ZENG Y, SI H, WU Y, et al. The incidence of symptomatic in-hospital VTEs in Asian patients undergoing joint arthroplasty was low: a prospective, multicenter, 17, 660-patient-enrolled cohort study[J]. Knee Surg Sports Traumatol Arthrosc, 2019, 27(4): 1075-1082. doi: 10.1007/s00167-018-5253-3
    [14]
    KLINE J A. Diagnosis and exclusion of pulmonary embolism[J]. Thromb Res, 2018, 163: 207-220. doi: 10.1016/j.thromres.2017.06.002
    [15]
    JENNINGS J D, SOLARZ M K, HAYDEL C. Application of tranexamic acid in trauma and orthopedic surgery[J]. Orthop Clin North Am, 2016, 47(1): 137-143. doi: 10.1016/j.ocl.2015.08.014
    [16]
    DIEBEL L N, MARTIN J V, LIBERATI D M. Early tranexamic acid administration ameliorates the endotheliopathy of trauma and shock in an in vitro model[J]. J Trauma Acute Care Surg, 2017, 82(6): 1080-1086. doi: 10.1097/TA.0000000000001445
    [17]
    HOWARD J T, STOCKINGER Z T, CAO A P, et al. Military use of tranexamic acid in combat trauma: does it matter?[J]. J Trauma Acute Care Surg, 2017, 83(4): 579-588. doi: 10.1097/TA.0000000000001613
    [18]
    周宗科, 翁习生, 曲铁兵, 等. 中国髋、膝关节置换术加速康复-围手术期管理策略专家共识[J]. 中华骨与关节外科杂志, 2016, 9(1): 1-9. doi: 10.3969/j.issn.2095-9985.2016.01.001
    [19]
    FILLINGHAM Y A, RAMKUMAR D B, JEVSEVAR D S, et al. Tranexamic acid in total joint arthroplasty: the endorsed clinical practice guides of the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society[J]. Reg Anesth Pain Med, 2019, 44(1): 7-11. doi: 10.1136/rapm-2018-000024
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(3)

    Article Metrics

    Article views (231) PDF downloads(4) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return